Welcome to Season 2 of the award-winning Precision Medicine Podcast
Clinical conversations about the effective use of precision medicine for cancer care.
Get the latest episode straight to your in-box.
EPISODE 41
Dr. Luis Raez Discusses the Impact of Precision Medicine on Lung Cancer Treatment
In this two-year anniversary episode and in honor of lung cancer awareness month, we spoke with Dr. Luis Raez who specializes in treating lung cancer. Hear how NGS has changed his approach to treating the disease, what notable discoveries in lung cancer have occurred over the last year, and how he sees COVID-19 impacting the treatment of cancer. Listen here
Airdate: 11.25.20 | Length: 35:30
EPISODE 40
Dr. Gabriel Bien-Willner: Reshaping Reimbursement Policies for Genetic and Genomic Testing
Dr. Gabriel A. Bien-Willner MD, PhD, FCAP, Medical Director at MolDX, and Chief Medical Officer at Palmetto GBA shares how he is supporting payers in gaining expertise and navigating the growing field of precision medicine through evidence-based decision-making. Listen here
Airdate: 10.29.20 | Length: 20:30
EPISODE 39
Breast Cancer Specialist Dr. Mark Moasser Discusses Overcoming Barriers to Clinical Trial Access
Dr. Mark Moasser, a physician-scientist and breast cancer specialist at the University of California, San Francisco discusses his research focus on the HER2 oncogene, the latest trial findings and the importance of improving patient access to clinical trials. Listen here
Airdate: 09.03.20 | Length: 24:20
EPISODE 38
Lori Brisbin Explains How Trapelo Helps Keep Texas Oncology Ahead of the Precision Medicine Curve
Lori Brisbin, Vice President of Precision Medicine at Texas Oncology, shares how this expansive network of oncologists is leveraging the web-based Trapelo™ platform to provide evidence-based decision support to its physicians and bring precision medicine to the forefront of patient care. Listen here
Airdate: 08.04.20 | Length: 15:42
OFFICIAL SPONSOR OF THE PRECISION MEDICINE PODCAST
EPISODE 37
Robin Toft on the Life Science Industry’s Talent Crisis, Advancement for Women, and Why It’s Critical for CEO’s to Focus on Diversity
Author and CEO of the Toft Group (a ZRG company), Robin Toft, joins us to discuss her new book, We Can, and share her thoughts on the need for more women and greater diversity in the C-suite and the boardroom within the life science industry. Listen here
Airdate: 07.01.20 | Length: 19:24
EPISODE 36
Dr. Roy Smythe Explains the Importance of Protein Expression in Practicing Precision Medicine
Physician scientist Dr. Roy Symthe discusses how, unlike genes, proteins are always changing and therefore can tell us something new about a patient’s current health state and potentially their future health state. Dr. Smythe is CEO of SomaLogic, a company that scans human proteins to gain insights into the past, current, and future health of patients, making it a promising new technology for precision medicine outcomes. Listen here
Airdate: 05.28.20 | Length: 30:11
EPISODE 35
The ROS1ders: Lung Cancer Patients Turned Precision Medicine Advocates and Superheros
Lung cancer patients Lisa Goldman and Tori Tomalia share their personal stories and motivation to create their organization, the ROS1ders, which advocates and supports those with ROS1-positive cancer— a group that represents just 2% of lung cancer patients. Listen here
Airdate: 04.29.20 | Length: 22:59
.jpg)
EPISODE 34
Dr. John Quackenbush Part 2: Embracing Biological Complexity to Realize the Potential of Precision Medicine
In our second podcast with Dr. John Quackenbush, Chair of the Department of Biostatistics at Harvard University's T.H. Chan School of Public Health, we delved deeper into his approach to understanding cancer by studying entire gene networks rather than simple mutations. Listen here
Airdate: 03.29.20 | Length: 15:50
EPISODE 33
The Impact of Precision Medicine on Gastrointestinal Disease
Dr. Arturo Loaiza-Bonilla, Chief Medical Officer and Director of Research for the Cancer Treatment Centers of America in Philadelphia, discusses how precision medicine is changing the treatment of GI cancers. Learn about the personal experiences that inspired his medical career focus and the hidden talent that nearly stole him away. Listen here
Airdate: 03.04.20 | Length: 24.53
_SM.png)
EPISODE 32
Precision Medicine is Here: Preparing a New Generation of Scientists to Apply It
Barbara Fortini, PhD, Program Director for the Master of Science in Human Genetics and Genomic Data Analytics at the Keck Graduate Institute shares what students of biology and genetics need to know today versus what they needed to know a decade ago, and how she sees those skills being applied in a clinical setting. Listen here
Airdate: 02.14.20 | Length: 30:35
Airdate: 01.24.20 | Length: 30:50
EPISODE 31
Dr. Adam Brufsky shares findings from the recent San Antonio Breast Cancer Symposium and the important role of precision medicine
In this episode of the Precision Medicine Podcast, Dr. Adam Brufsky, Medical Director for the Women’s Cancer Program at the UPMC Hillman Cancer Center shares the newest findings presented in December 2019 at the San Antonio Breast Cancer Symposium (SABCS) and discusses the important role of precision medicine in breast cancer care. Listen here
EPISODE 30
Dr. John Quackenbush Part 1: Using Massive Data to Approach Precision Medicine Beyond Simple Mutations
In this first episode of season two, Dr. John Quackenbush discusses his approach to understanding what makes cancer cancer by studying entire gene networks rather than simple mutations. Dr. Quackenbush is Chair of the Department of Biostatistics at Harvard University's T.H. Chan School of Public Health and one of the first people to have worked on the Human Genome Project.
Airdate: 01.09.20 | Length: 24:10
How can we resolve the complexities of using precision medicine for cancer care?
Trapelo knows.
